World Journal of Diabetes - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6135)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series.

Item

Count

PDF

345

WORD

159

HTML

3075

Figures (1-5)

437

Sum=4016

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

599

Download

1520

Sum=2119

Apr 15, 2021 (publication date) through Mar 29, 2025

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Jia JD, Jiang WG, Luo X, Li RR, Zhao YC, Tian G, Li YN. Vascular endothelial growth factor B inhibits insulin secretion in MIN6 cells and reduces Ca²⁺ and cyclic adenosine monophosphate levels through PI3K/AKT pathway. World J Diabetes 2021; 12(4): 480-498 [PMID: 33889292 DOI: 10.4239/wjd.v12.i4.480]
URL:	https://www.wjgnet.com/1948-9358/full/v12/i4/480.htm

Number	Citing Articles
1	Jian Xu, Mindi Yin, Jian Zhao, Chao Xu, Zihan Mao. Mechanism of miR-21 Antagonist Packaged with Arsenic Trioxide (As2O3) Nanoparticles in Restraining Invasion and Metastasis of Intestinal Cancer by Targeted C-C Motif Chemokine Receptor 7 (CCR7) Protein Through Induction of PI3K/Akt Signal Pathway. Science of Advanced Materials 2021; 13(11): 2075 doi: 10.1166/sam.2021.4095
2	Yu-Qi Li, Lei Xin, Yu-Chi Zhao, Shang-Qi Li, Ya-Nuo Li. Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value. World Journal of Hepatology 2023; 15(6): 786-796 doi: 10.4254/wjh.v15.i6.786 Abstract(623) \| Core Tip(643) \| Full Article(HTML)(2483) \| Full Article with Cover (PDF)-6903K(104) \| Full Article (Word)-1481K(25) \| Audio-386K(6) \| Peer-Review Report-428K(66) \| Answering Reviewers-597K(72) \| Full Article (PDF)-4574K(173) \| Full Article (XML)-147K(69) \| Times Cited (5) \| Total Visits (6710) \| Open
3	Jinhao Liu, Lulu Quan, Junfeng Wang, Gonghao Zhang, Lilin Cai, Zhe Pan, Shilong Liu, Canjun Zhu, Ruifan Wu, Lina Wang, Gang Shu, Qingyan Jiang, Songbo Wang. Knockdown of VEGF-B improves HFD-induced insulin resistance by enhancing glucose uptake in vascular endothelial cells via the PI3K/Akt pathway. International Journal of Biological Macromolecules 2025; 285: 138279 doi: 10.1016/j.ijbiomac.2024.138279
4	Yu-Qi Li, Lu-Yang Zhang, Yu-Chi Zhao, Fang Xu, Zhi-Yong Hu, Qi-Hao Wu, Wen-Hao Li, Ya-Nuo Li. Vascular endothelial growth factor B improves impaired glucose tolerance through insulin-mediated inhibition of glucagon secretion. World Journal of Diabetes 2023; 14(11): 1643-1658 doi: 10.4239/wjd.v14.i11.1643 Abstract(745) \| Core Tip(659) \| Full Article(HTML)(1595) \| Full Article with Cover (PDF)-17482K(113) \| Full Article (Word)-4980K(33) \| Audio-480K(6) \| Peer-Review Report-336K(78) \| Answering Reviewers-177K(68) \| Full Article (PDF)-17274K(137) \| Full Article (XML)-161K(70) \| Times Cited (1) \| Total Visits (5847) \| Open